Integrated BioPharma Inc. (OTCMKTS:INBP – Get Free Report)’s share price passed above its 50-day moving average during trading on Monday. The stock has a 50-day moving average of $0.17 and traded as high as $0.1750. Integrated BioPharma shares last traded at $0.1750, with a volume of 16,600 shares traded.
Integrated BioPharma Trading Up 6.0%
The firm has a market capitalization of $5.42 million, a price-to-earnings ratio of -1.46 and a beta of 0.49. The firm has a 50 day moving average price of $0.17 and a two-hundred day moving average price of $0.22.
Integrated BioPharma (OTCMKTS:INBP – Get Free Report) last issued its earnings results on Friday, November 13th. The company reported ($0.02) earnings per share (EPS) for the quarter. The firm had revenue of $9.91 million for the quarter. Integrated BioPharma had a negative return on equity of 14.78% and a negative net margin of 6.48%.
Integrated BioPharma Company Profile
Integrated BioPharma, Inc. develops, manufactures and distributes vitamins, nutritional supplements, herbal products and other health and wellness products. Its activities include contract manufacturing for customers as well as the distribution of health-related products.
Read More
- Five stocks we like better than Integrated BioPharma
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Integrated BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
